Cargando…
A NOVEL INDEX OF WHOLE BODY ANTILIPOLYTIC INSULIN ACTION
Assessment of antilipolytic insulin action is important in obesity research, but extensive isotopic tracer studies are not always feasible. We evaluated whether an index of antilipolytic insulin action could be derived from readily available insulin and glycerol concentrations obtained during clamps...
Autores principales: | Van Pelt, R.E., Gozansky, W.S., Kohrt, W.M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3469744/ https://www.ncbi.nlm.nih.gov/pubmed/23505199 http://dx.doi.org/10.1038/oby.2012.183 |
Ejemplares similares
-
A randomized trial of estrogen or raloxifene during postmenopausal weight loss: Adiposity and cardiometabolic outcomes
por: Van Pelt, R.E., et al.
Publicado: (2013) -
PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
por: Yin, Chunyan, et al.
Publicado: (2019) -
Insulin-mimetic compound hexaquis (benzylammonium) decavanadate is antilipolytic in human fat cells
por: Carpéné, Christian, et al.
Publicado: (2017) -
A longitudinal study of the antilipolytic effect of insulin in women following bariatric surgery
por: Kwok, Kelvin Ho Man, et al.
Publicado: (2021) -
Correction: PID1 alters the antilipolytic action of insulin and increases lipolysis via inhibition of AKT/PKA pathway activation
por: Yin, Chunyan, et al.
Publicado: (2019)